HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 37 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $230,723 | -39.1% | 13,620 | -56.9% | 0.00% | – |
Q2 2023 | $378,948 | -50.3% | 31,579 | -46.0% | 0.00% | – |
Q1 2023 | $761,787 | -76.3% | 58,509 | -73.1% | 0.00% | -100.0% |
Q4 2022 | $3,219,276 | +424.3% | 217,813 | +214.1% | 0.00% | – |
Q3 2022 | $614,000 | +18.3% | 69,343 | +368.9% | 0.00% | – |
Q4 2021 | $519,000 | -47.4% | 14,790 | -45.1% | 0.00% | – |
Q3 2021 | $987,000 | -44.3% | 26,948 | -40.3% | 0.00% | – |
Q2 2021 | $1,773,000 | +120.2% | 45,118 | +58.4% | 0.00% | – |
Q1 2021 | $805,000 | -26.7% | 28,492 | -28.4% | 0.00% | – |
Q2 2020 | $1,098,000 | +48.8% | 39,812 | -3.7% | 0.00% | – |
Q1 2020 | $738,000 | -19.3% | 41,344 | +13.4% | 0.00% | – |
Q4 2019 | $914,000 | -37.0% | 36,455 | -55.2% | 0.00% | -100.0% |
Q3 2019 | $1,451,000 | -18.9% | 81,321 | -0.0% | 0.00% | 0.0% |
Q2 2019 | $1,790,000 | +744.3% | 81,346 | +1057.3% | 0.00% | – |
Q2 2018 | $212,000 | -25.9% | 7,029 | -27.3% | 0.00% | – |
Q1 2018 | $286,000 | – | 9,674 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zeal Asset Management Ltd | 2,684,118 | $84,523,000 | 16.48% |
Cederberg Capital Ltd | 3,400,000 | $108,868,000 | 2.00% |
Capital International Sarl | 570,500 | $18,267,000 | 1.91% |
AIA Group Ltd | 437,118 | $14,971,000 | 1.72% |
Capital International, Inc./CA/ | 4,711,405 | $150,859,000 | 1.40% |
M&G INVESTMENT MANAGEMENT LTD | 3,096,345 | $99,083,000 | 0.62% |
Bellevue Group AG | 947,674 | $30,345,000 | 0.35% |
Sands Capital Management | 7,051,916 | $225,802,000 | 0.22% |
E Fund Management (Hong Kong) Co., Ltd. | 18,836 | $603,000 | 0.21% |
Hudson Bay Capital Management LP | 1,031,212 | $33,020,000 | 0.18% |